TheresaA.GuiseMDFASBMR
Endocrinology • Houston, TXDiabetes, Lipid Metabolism
Professor and Section Chief, Disorders of Bone and Mineral Metabolism, Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center Co-Leader, Bone Disease Program of Texas Scholar, Cancer Prevention Research Institute of Texas (CPRIT)
Dr. Guise is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6565 MD Anderson Lane
Zayed Building, Room Z8.3028
Houston, TX 77030Phone+1 713-563-2848- Is this information wrong?
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
UPMC Medical EducationResidency, Internal Medicine, 1985 - 1988
University of Pittsburgh School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 1989 - 2024
IN State Medical License 2009 - 2021
VA State Medical License 2002 - 2010
PA State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2018
- Philip S. Hench Distinguished Alumnus Award University of Pittsburgh School of Medicine, 2017
- Paula Stern Achievement Award American Society for Bone and Mineral Research, 2012
- Join now to see all
Publications & Presentations
PubMed
- Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice.Yang Liu, Steven Reiken, Haikel Dridi, Qi Yuan, Khalid S Mohammad, Trupti Trivedi, Marco C Miotto, Kaylee Wedderburn-Pugh, Leah Sittenfeld, Ynez Kerley, Jill A Meyer, ...> ;Science Translational Medicine. 2023 Sep 27
- 1 citationsGeneralizability of a Machine Learning Model for Improving Utilization of Parathyroid Hormone-Related Peptide Testing across Multiple Clinical Centers.He S Yang, Weishen Pan, Yingheng Wang, Mark A Zaydman, Nicholas C Spies, Zhen Zhao, Theresa A Guise, Qing H Meng, Fei Wang> ;Clinical Chemistry. 2023 Nov 2
- 5 citationsCare after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.Denise R Nebgen, Susan M Domchek, Joanne Kotsopoulos, Joanne A de Hullu, Emma J Crosbie, Vincent Singh Paramanandam, Monique M A Brood-van Zanten, Barbara M Norquist, ...> ;BJOG. 2023 Nov 1
- Join now to see all
Press Mentions
Abstracts from the Bone and Muscle Interactions: The Mechanical and Beyond Meeting August 2019May 16th, 2020
Chair Yoga for My Funny BonesAugust 10th, 2017
Researchers Find Pathway to Cancer-Associated Muscle WeaknessOctober 13th, 2015- Join now to see all
Grant Support
- Differential Tgf-Beta Signaling In Bone Microenviroment: Impact On Tumor GrowthNational Cancer Institute2011–2012
- Tgfbeta In The Bone Microenvironment: Role In Tumor MetastasisNational Cancer Institute2010–2012
- Prostate Cancer Bone Metastases: Role Of AdrenomedullinNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- Tgfbeta In The Bone Microenvironment: Role In Tumor MetastasisNational Cancer Institute2008–2009
- Cell, Animal And Imaging CoreNational Cancer Institute2008–2009
- Prostate Cancer Bone Metastases: Role Of AdrenomedullinNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Endothelin-1 In Normal And Pathological Bone RemodelingNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
- Breast Cancer Osteolysis--Regulation Of Pthrp By TgfbetaNational Cancer Institute2002–2007
- Breast Cancer Osteolysis--Regulation Of Pthrp By TgfbetaNational Cancer Institute2001–2002
- Molecular Mechanisms Of Osteoblastic Bone Metastasis: Role Of Endothelin-1National Cancer Institute1999–2002
- Breast Cancer Metastases To Bone--Role Of Pthrp &TgfbNational Cancer Institute1996–2000
- Humoral Hypercalcemia Of MalignancyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–1997
- Animal Models Of Humoral Hypercalcemia Of MalignancyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1993
- Animal Models Of Humoral Hypercalcemia Of MalignancyNational Cancer Institute1991
Committees
- Member 2017-8; Chair-elect 2019; Chair 2020, Tumor Microenvironment Steering Committee of the AACR 2018 - Present
Professional Memberships
- American Society for Bone and Mineral ResearchMember
- Member
- Member
- Member
- American Society for Clinical InvestigationMember
- Cancer and Bone SocietyMember
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
